Status:
RECRUITING
App-based Motivational Interviewing and Artificial Intelligence in Diabetes Management
Lead Sponsor:
Singapore General Hospital
Collaborating Sponsors:
SingHealth Polyclinic - Sengkang
SingHealth Polyclinic - Punggol
Conditions:
Diabetes Mellitus Type 2
Eligibility:
All Genders
21-100 years
Phase:
NA
Brief Summary
There is an urgent need for better control and prevention of complications in type 2 diabetes mellitus (T2DM). Behavioural change is critical, and while literature suggests that motivational interview...
Eligibility Criteria
Inclusion
- Aged 21 years and above
- Have been diagnosed with diabetes (T2DM)
- Had HbA1c result of ≥ 7.5% within past 3 months
- Physically able to exercise
- Able to read and converse in English
- Able to download the Empower+ app, use the smartphone wearable tracker, and conform to the minimum smartwatch and app monitoring schedule
Exclusion
- On bolus insulin treatment
- Require assistance with basic activities of daily living (BADL)
- Have planned major operation or surgical procedure within 9 months from the time of recruitment
- Cognitively impaired (scored \< 6 on the Abbreviated Mental Test)
- Currently pregnant or lactating
- Current participants of ongoing clinical trials involving the usage of a smartphone wearable tracker or mobile health app to assist diabetes management
- Past Empower study participants who refused to participate in future Empower studies
Key Trial Info
Start Date :
February 23 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2026
Estimated Enrollment :
525 Patients enrolled
Trial Details
Trial ID
NCT06214520
Start Date
February 23 2024
End Date
June 30 2026
Last Update
November 14 2024
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
SingHealth Polyclinic (Punggol)
Singapore, Singapore
2
SingHealth Polyclinic (Sengkang)
Singapore, Singapore
3
SingHealth Polyclinic (Tampines)
Singapore, Singapore